Search research articles
Contact Us
Filters
Showing results (61-70 of 638) with videos related to
Page
of 64
Sort By:
Journal of Hepatology
|
December 3, 2014
Molecular mechanism of PPARα action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease
Michal Pawlak, Philippe Lefebvre, Bart Staels
Methods in Molecular Biology (Clifton, N.J.)
|
October 27, 2012
PPAR SUMOylation: some useful experimental tips
Benoit Pourcet, Bart Staels, Corine Glineur
Trends in Cell Biology
|
November 8, 2024
Increased O-GlcNAcylation connects metabolic to transcriptional reprogramming during pathophysiological cell activation
Ninon Very, Bart Staels, Jérôme Eeckhoute
Journal of Hepatology
|
July 17, 2023
Treating NASH by targeting peroxisome proliferator-activated receptors
Bart Staels, Laura Butruille, Sven Francque
Current Topics in Medicinal Chemistry
|
January 17, 2012
General molecular biology and architecture of nuclear receptors
Michal Pawlak, Philippe Lefebvre, Bart Staels
Trends in Endocrinology and Metabolism: TEM
|
August 3, 2010
Retinoid X receptors: common heterodimerization partners with distinct functions
Philippe Lefebvre, Yacir Benomar, Bart Staels
Nature Clinical Practice. Cardiovascular Medicine
|
July 17, 2008
Fibrates and future PPARalpha agonists in the treatment of cardiovascular disease
Bart Staels, Michel Maes, Alberto Zambon
STAR Protocols
|
July 21, 2021
An optimized protocol with a stepwise approach to identify specific nuclear receptor ligands from cultured mammalian cells
Alexandre Berthier, Bart Staels, Philippe Lefebvre
EMBO Reports
|
April 16, 2011
EMBO workshop on immunology and metabolism
Bart Staels, David Dombrowicz, Ursula Grohmann
Biochemical Pharmacology
|
December 17, 2011
DPP-4 inhibitors in the treatment of type 2 diabetes
Hélène Duez, Bertrand Cariou, Bart Staels
Page
of 64
Search research articles
Search
Showing results (61-70 of 638) with videos related to
Sort By:
Page
of 64
Journal of Hepatology
|
December 3, 2014
Molecular mechanism of PPARα action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease
Michal Pawlak, Philippe Lefebvre, Bart Staels
Methods in Molecular Biology (Clifton, N.J.)
|
October 27, 2012
PPAR SUMOylation: some useful experimental tips
Benoit Pourcet, Bart Staels, Corine Glineur
Trends in Cell Biology
|
November 8, 2024
Increased O-GlcNAcylation connects metabolic to transcriptional reprogramming during pathophysiological cell activation
Ninon Very, Bart Staels, Jérôme Eeckhoute
Journal of Hepatology
|
July 17, 2023
Treating NASH by targeting peroxisome proliferator-activated receptors
Bart Staels, Laura Butruille, Sven Francque
Current Topics in Medicinal Chemistry
|
January 17, 2012
General molecular biology and architecture of nuclear receptors
Michal Pawlak, Philippe Lefebvre, Bart Staels
Trends in Endocrinology and Metabolism: TEM
|
August 3, 2010
Retinoid X receptors: common heterodimerization partners with distinct functions
Philippe Lefebvre, Yacir Benomar, Bart Staels
Nature Clinical Practice. Cardiovascular Medicine
|
July 17, 2008
Fibrates and future PPARalpha agonists in the treatment of cardiovascular disease
Bart Staels, Michel Maes, Alberto Zambon
STAR Protocols
|
July 21, 2021
An optimized protocol with a stepwise approach to identify specific nuclear receptor ligands from cultured mammalian cells
Alexandre Berthier, Bart Staels, Philippe Lefebvre
EMBO Reports
|
April 16, 2011
EMBO workshop on immunology and metabolism
Bart Staels, David Dombrowicz, Ursula Grohmann
Biochemical Pharmacology
|
December 17, 2011
DPP-4 inhibitors in the treatment of type 2 diabetes
Hélène Duez, Bertrand Cariou, Bart Staels
Page
of 64